pyrrolidine dithiocarbamate has been researched along with aprepitant in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishimaru, Y; Narahara, S; Sakamoto, A; Sugiuchi, H; Yamaguchi, R; Yamaguchi, Y; Yamamoto, T | 1 |
1 other study(ies) available for pyrrolidine dithiocarbamate and aprepitant
| Article | Year |
|---|---|
Substance P enhances tissue factor release from granulocyte-macrophage colony-stimulating factor-dependent macrophages via the p22phox/β-arrestin 2/Rho A signaling pathway.
Topics: Acetophenones; Adipocytes; Amides; Aprepitant; Arrestins; Benzopyrans; beta-Arrestin 2; beta-Arrestins; Dynamins; Free Radical Scavengers; Gene Expression Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Macrophage Activation; Macrophages; Morpholines; NADPH Oxidases; Neurokinin-1 Receptor Antagonists; Phosphorylcholine; Primary Cell Culture; Protein Kinase Inhibitors; Pyridines; Pyrrolidines; rho-Associated Kinases; RNA, Small Interfering; Signal Transduction; Substance P; Thiocarbamates; Thromboplastin | 2016 |